Evidence map›Paper›PMID 39948700›Full record

ReviewClinical & experimental ophthalmology2025

Strabismus in Genetic Syndromes: A Review.

Seyda Kilic, Jillian Bove, Bethany Nahri So, Mary C Whitman

Abstract readReview
In one paragraph

Review in Clinical & experimental ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Seyda KilicDepartment of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts, USA.
Jillian BoveDepartment of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts, USA.
Bethany Nahri SoHarvard Medical School, Boston, Massachusetts, USA.
Mary C WhitmanDepartment of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts, USA.ORCID 0000-0001-6297-7499

Funding

Molecular mechanisms underlying strabismus riskR01EY032539 · NEI · BOSTON CHILDREN'S HOSPITAL · PI Mary Catherine Whitman · 2022 to 2026
$3.3M
Development of Oculomotor Circuits in NystagmusR01EY034846 · NEI · BOSTON CHILDREN'S HOSPITAL · PI Mary Catherine Whitman · 2024 to 2026
$1.3M
Children's Hospital Ophthalmology FoundationHarvard Medical School Office of Scholarly EngagementNEI NIH HHS R01 EY032539NEI NIH HHS R01 EY034846NEI NIH HHS R01EY034846
6 · The paper itself

Abstract

Strabismus is a feature of many genetic syndromes, with highly variable penetrance. The congenital cranial dysinnervation disorders (CCDDs) result in paralytic strabismus, with limited eye movements. CCDDs result from either deficits in differentiation of the cranial motor neuron precursors or from abnormal axon guidance of the cranial nerves. Although most individuals with comitant strabismus are otherwise healthy, strabismus is a variable feature of many genetic syndromes, most commonly those associated with intellectual disability. We review 255 genetic syndromes in which strabismus has been described and discuss the variable penetrance. The association with intellectual disability and neurological disorders underscores the likely neurological basis of strabismus, but the variable penetrance emphasises the complexity of strabismus pathophysiology. The syndromes described here mostly result from loss of function or change in function of the responsible genes; one hypothesis is that nonsyndromic strabismus may result from altered expression or regulation of the same genes.

Indexed as

StrabismusHumansOculomotor MusclesPenetranceSyndromecongenital cranial dysinnervation disordersgeneticsintellectual disabilitypenetrancestrabismus

Identifiers

PMID39948700
PMCPMC12684813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.